A spatial human thymus cell atlas mapped to a continuous tissue axis.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
pubmed:
21
11
2023
medline:
21
11
2023
entrez:
21
11
2023
Statut:
epublish
Résumé
T cells develop from circulating precursors, which enter the thymus and migrate throughout specialised sub-compartments to support maturation and selection. This process starts already in early fetal development and is highly active until the involution of the thymus in adolescence. To map the micro-anatomical underpinnings of this process in pre- vs. post-natal states, we undertook a spatially resolved analysis and established a new quantitative morphological framework for the thymus, the Cortico-Medullary Axis. Using this axis in conjunction with the curation of a multimodal single-cell, spatial transcriptomics and high-resolution multiplex imaging atlas, we show that canonical thymocyte trajectories and thymic epithelial cells are highly organised and fully established by post-conception week 12, pinpoint TEC progenitor states, find that TEC subsets and peripheral tissue genes are associated with Hassall's Corpuscles and uncover divergence in the pace and drivers of medullary entry between CD4 vs. CD8 T cell lineages. These findings are complemented with a holistic toolkit for spatial analysis and annotation, providing a basis for a detailed understanding of T lymphocyte development.
Identifiants
pubmed: 37986877
doi: 10.1101/2023.10.25.562925
pmc: PMC10659407
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Déclaration de conflit d'intérêts
Conflict of interest J.C.M has been an employee of Genentech, Inc. since September 2022. In the past three years, S.A.T. has consulted for or been a member of scientific advisory boards at Qiagen, Sanofi, GlaxoSmithKline, and ForeSite Labs. She is a consultant and equity holder for TransitionBio and EnsoCell. The remaining authors declare no competing interests.
Références
Front Immunol. 2012 Mar;3(March):19
pubmed: 22448160
Nature. 2000 Mar 30;404(6777):506-10
pubmed: 10761920
Nat Biotechnol. 2023 Apr 13;:
pubmed: 37055623
Trends Immunol. 2022 Oct;43(10):782-791
pubmed: 36008259
Cell Rep. 2016 Mar 29;14(12):2819-32
pubmed: 26997270
Aging Dis. 2012 Jun;3(3):280-90
pubmed: 22724086
J Digit Imaging. 2018 Jun;31(3):290-303
pubmed: 29181613
Ann Anat. 2017 May;211:140-148
pubmed: 28279759
Nature. 2022 Jun;606(7912):165-171
pubmed: 35614226
Elife. 2017 Dec 05;6:
pubmed: 29206104
Front Immunol. 2021 Apr 02;12:635569
pubmed: 33868260
Immunity. 1996 Nov;5(5):461-77
pubmed: 8934573
J Immunol. 2022 Jul 15;209(2):199-207
pubmed: 35821102
Int Immunol. 2019 Mar 5;31(3):127-139
pubmed: 30534943
Nature. 2018 Nov;563(7731):347-353
pubmed: 30429548
Nat Rev Genet. 2022 Dec;23(12):741-759
pubmed: 35859028
J Pathol Inform. 2021 Dec 16;12:52
pubmed: 35070481
Nat Commun. 2023 Jul 10;14(1):4071
pubmed: 37429879
Int J Appl Basic Med Res. 2012 Jan;2(1):7-10
pubmed: 23776800
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33455-33465
pubmed: 33376221
J Immunol. 2000 Aug 15;165(4):1889-95
pubmed: 10925269
Nature. 2018 Jul;559(7715):622-626
pubmed: 30022162
Nat Biotechnol. 2019 Apr;37(4):451-460
pubmed: 30899105
Cell. 2022 Jul 7;185(14):2542-2558.e18
pubmed: 35714609
Cell. 2019 Dec 12;179(7):1455-1467
pubmed: 31835027
Nature. 2005 Aug 25;436(7054):1181-5
pubmed: 16121185
J Neuroimmunol. 2014 Apr 15;269(1-2):56-61
pubmed: 24556356
Lancet. 1961 Sep 30;2(7205):748-9
pubmed: 14474038
Nat Rev Immunol. 2008 Jan;8(1):9-21
pubmed: 18097446
Blood. 2001 Feb 15;97(4):850-7
pubmed: 11159507
Nature. 2019 Oct;574(7777):187-192
pubmed: 31597973
Nature. 2006 Jun 22;441(7096):988-91
pubmed: 16791197
Cell Mol Life Sci. 2014 Aug;71(16):3101-17
pubmed: 24682469
Nat Commun. 2022 Apr 19;13(1):2099
pubmed: 35440536
Cell. 2018 Aug 9;174(4):968-981.e15
pubmed: 30078711
Immunity. 2006 Feb;24(2):165-77
pubmed: 16473829
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Blood. 2001 Feb 1;97(3):601-7
pubmed: 11157474
EMBO J. 2020 Jan 2;39(1):e101828
pubmed: 31657037
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
J Exp Med. 1984 Apr 1;159(4):1149-68
pubmed: 6200562
Nat Rev Immunol. 2020 Dec;20(12):756-770
pubmed: 32581346
Elife. 2022 Nov 30;11:
pubmed: 36449334
Metabolism. 1970 Jun;19(6):401-5
pubmed: 5444243
J Exp Med. 2010 Oct 25;207(11):2521-32
pubmed: 20937703
Nat Biotechnol. 2022 May;40(5):661-671
pubmed: 35027729
Immunity. 2020 Jun 16;52(6):1088-1104.e6
pubmed: 32304633
Immunity. 2020 Jun 16;52(6):1105-1118.e9
pubmed: 32553173
Bioinformatics. 2023 Jan 1;39(1):
pubmed: 36394263
Nat Methods. 2022 Mar;19(3):284-295
pubmed: 34811556
Nat Methods. 2018 Dec;15(12):1053-1058
pubmed: 30504886
Eur J Immunol. 2015 Aug;45(8):2218-31
pubmed: 25973789
Sci Rep. 2018 Jan 12;8(1):685
pubmed: 29330484
Semin Arthritis Rheum. 2010 Apr;39(5):347-55
pubmed: 18973928
Nat Methods. 2023 Sep;20(9):1323-1335
pubmed: 37550580
Science. 2022 Jun 3;376(6597):eabo0510
pubmed: 35549310
Nature. 1984 Jun 14-20;309(5969):629-31
pubmed: 6374470
Front Genet. 2017 Jan 10;7:227
pubmed: 28119736
Nat Rev Immunol. 2011 Jun 24;11(7):469-77
pubmed: 21701522
Nat Commun. 2020 Dec 11;11(1):6372
pubmed: 33311516
J Clin Invest. 2017 Jun 1;127(6):2378-2391
pubmed: 28481227
Science. 2022 May 13;376(6594):eabl4290
pubmed: 35549429
Nat Methods. 2013 Sep;10(9):857-60
pubmed: 23852452
Immunity. 2019 Nov 19;51(5):930-948.e6
pubmed: 31604687
Front Immunol. 2023 Jan 20;13:1092028
pubmed: 36741401
J Immunol. 2017 Mar 15;198(6):2310-2319
pubmed: 28159903
Development. 2013 May;140(9):2015-26
pubmed: 23571219
Science. 2020 Feb 21;367(6480):
pubmed: 32079746
J Exp Med. 2003 Sep 15;198(6):957-62
pubmed: 12975459
J Clin Immunol. 1987 Mar;7(2):81-97
pubmed: 2437143
Gut. 2006 Jul;55(7):961-8
pubmed: 16368781
Nat Biotechnol. 2018 Jun;36(5):421-427
pubmed: 29608177
J Exp Med. 2001 Jul 16;194(2):127-34
pubmed: 11457887
Cell Syst. 2019 Apr 24;8(4):281-291.e9
pubmed: 30954476
Nat Immunol. 2023 Sep;24(9):1579-1590
pubmed: 37580604
Nat Immunol. 2020 Oct;21(10):1172-1180
pubmed: 32839611
Eur J Immunol. 2011 Dec;41(12):3604-14
pubmed: 21932449
J Immunol. 2008 Dec 15;181(12):8199-203
pubmed: 19050235
Toxicol Pathol. 2006;34(5):504-14
pubmed: 17067941
Nat Commun. 2021 Feb 17;12(1):1096
pubmed: 33597545
Immunol Lett. 2013 Jul-Aug;154(1-2):31-41
pubmed: 23912054
Rom J Morphol Embryol. 2021 Jan-Mar;62(1):73-83
pubmed: 34609410
Science. 2022 May 13;376(6594):eabl5197
pubmed: 35549406
Nat Immunol. 2001 Nov;2(11):1032-9
pubmed: 11600886
Dev Cell. 2023 Nov 20;58(22):2428-2446.e9
pubmed: 37652013
Annu Rev Cell Dev Biol. 2011;27:539-62
pubmed: 21740230
Nat Protoc. 2022 Feb;17(2):378-401
pubmed: 35022622
Nat Cancer. 2023 Jul;4(7):1036-1052
pubmed: 37349501
Science. 2019 Mar 15;363(6432):
pubmed: 30872492
Nat Rev Immunol. 2020 Apr;20(4):239-253
pubmed: 31804611
Front Immunol. 2017 Jan 20;8:32
pubmed: 28163708
Science. 2002 Nov 15;298(5597):1395-401
pubmed: 12376594
Front Med (Lausanne). 2022 Mar 04;8:777619
pubmed: 35356049
Semin Immunopathol. 2021 Feb;43(1):29-43
pubmed: 33449155
J Exp Med. 2019 Aug 5;216(8):1749-1761
pubmed: 31201207
Nature. 2021 Jan;589(7840):131-136
pubmed: 33239787
Elife. 2023 Jun 02;12:
pubmed: 37266571
Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19490-19499
pubmed: 31501331
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
Sci Rep. 2017 Jul 11;7(1):5068
pubmed: 28698642
Nat Commun. 2020 Aug 28;11(1):4318
pubmed: 32859930
Front Neuroinform. 2013 Dec 30;7:45
pubmed: 24416015
Nat Rev Immunol. 2002 Oct;2(10):760-72
pubmed: 12360214